An analysis published this week in JAMA Internal Medicine found that most participants in a clinical trial who were assigned to stop taking tirzepatide (Zepbound from Eli Lilly) not only regained significant amounts of the weight they had lost on the drug, but they also saw their cardiovascular and metabolic improvements slip away
Lipo-C is a compounded lipotropic used for injection
Although the FDA has yet to approve a closed-loop artificial pancreas system, research is ongoing and these devices will likely become increasingly available in the coming years as technology improves (FDA 2016)
After this week, you can begin Mounjaro
11 Lack of supply There is a shortage of both semaglutide and tirzepatide due to their unprecedented demand, with both now listed in the FDA Drug Shortages database, allowing for compounded versions to be made (although that does not make such versions FDA-approved)
Doubling the units to "make up" for a missed dose is dangerous and unnecessary